These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19289645)

  • 1. Letter by Hartog et al. regarding article, "Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines".
    Hartog JW; Willemsen S; Voors AA
    Circulation; 2009 Mar; 119(10):e233; author reply e234. PubMed ID: 19289645
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines.
    Shapiro BP; Owan TE; Mohammed SF; Meyer DM; Mills LD; Schalkwijk CG; Redfield MM
    Circulation; 2008 Sep; 118(10):1002-10. PubMed ID: 18711013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen.
    Urios P; Grigorova-Borsos AM; Sternberg M
    Diabetes Res Clin Pract; 2007 Aug; 77(2):337-40. PubMed ID: 17383766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
    Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
    Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties.
    Winlove CP; Parker KH; Avery NC; Bailey AJ
    Diabetologia; 1996 Oct; 39(10):1131-9. PubMed ID: 8896999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amount of N(omega)-(Carboxymethyl)arginine generated in collagen and bovine serum albumin during glycation reactions is significantly different.
    Iijima K; Fujimoto D; Irie S
    Connect Tissue Res; 2007; 48(5):271-6. PubMed ID: 17882703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification of muscle protein in diabetes.
    Alt N; Carson JA; Alderson NL; Wang Y; Nagai R; Henle T; Thorpe SR; Baynes JW
    Arch Biochem Biophys; 2004 May; 425(2):200-6. PubMed ID: 15111128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levels of mature cross-links and advanced glycation end product cross-links in human vitreous].
    Matsumoto Y; Takahashi M; Chikuda M; Arai K
    Nippon Ganka Gakkai Zasshi; 2002 Jan; 106(1):9-15. PubMed ID: 11828768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes.
    Sady C; Khosrof S; Nagaraj R
    Biochem Biophys Res Commun; 1995 Sep; 214(3):793-7. PubMed ID: 7575546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation of rat liver histone octamers: an in vitro study.
    Gugliucci A
    Biochem Biophys Res Commun; 1994 Aug; 203(1):588-93. PubMed ID: 8074708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonenzymatic glycation of histones in vitro and in vivo.
    Talasz H; Wasserer S; Puschendorf B
    J Cell Biochem; 2002; 85(1):24-34. PubMed ID: 11891847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle.
    Haus JM; Carrithers JA; Trappe SW; Trappe TA
    J Appl Physiol (1985); 2007 Dec; 103(6):2068-76. PubMed ID: 17901242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
    Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoselective synthesis of peptides containing major advanced glycation end-products of lysine and arginine.
    Gruber P; Hofmann T
    J Pept Res; 2005 Sep; 66(3):111-24. PubMed ID: 16083438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-arginine advanced glycation end-product cross-links and the effect on collagen structure: A molecular dynamics study.
    Nash A; Noh SY; Birch HL; de Leeuw NH
    Proteins; 2021 May; 89(5):521-530. PubMed ID: 33320391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
    Bakris GL; Bank AJ; Kass DA; Neutel JM; Preston RA; Oparil S
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):23S-30S. PubMed ID: 15607432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between vascular endothelial growth factors and advanced glycation end products in the human vitreous].
    Hashimoto H; Arai K; Chikuda M; Obara Y
    Nippon Ganka Gakkai Zasshi; 1998 Jul; 102(7):442-6. PubMed ID: 9720366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave-assisted Maillard reactions for the preparation of advanced glycation end products (AGEs).
    Visentin S; Medana C; Barge A; Giancotti V; Cravotto G
    Org Biomol Chem; 2010 May; 8(10):2473-7. PubMed ID: 20448908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxidative stress marker].
    Katayama S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():142-6. PubMed ID: 16981533
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites.
    Cervantes-Laurean D; Schramm DD; Jacobson EL; Halaweish I; Bruckner GG; Boissonneault GA
    J Nutr Biochem; 2006 Aug; 17(8):531-40. PubMed ID: 16443355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.